• Latest Posts

CHMP recommends approval of Beyfortus for prevention of RSV disease in infants

Synairgen to collaborate on study of patients hospitalized due to respiratory viruses

Encouraging results from respiratory diseases vaccine trial

Biotechs Carve out Niches in Cystic Fibrosis Treatment Space

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology


Viral Vaccines Could Be Weapons Against Alzheimer’s Disease

More News! 14 Jan 2019

Inhaled Lung Disease Treatment Encounters Mixed Results in Phase II Trial

More News! 20 Dec 2018

Cambridge Company Raises €20M for Potential First in Lung Disease

London Biotech Raises €47M to Develop First Treatment Against RSV Virus

British Biotech Raises £29M Round to Fight Lung Disease